Secretary Kennedy Appoints Two Physicians to CDC's Advisory Committee on Immunization Practices

Why It Matters

Adding seasoned clinicians gives ACIP practical insights that can sharpen vaccine recommendations and rebuild public confidence, supporting higher immunization rates and a more agile response to emerging health threats.

Key Takeaways

• Kennedy reconstituted ACIP in June 2025.
• Two physicians added: Dr. Downing and Dr. Farella.
• Both have over two decades primary care experience.
• Appointments aim to boost transparency and public trust.
• ACIP advises CDC and HHS on vaccine policy.

Pulse Analysis

The Advisory Committee on Immunization Practices (ACIP) serves as the nation’s principal advisory body for vaccine policy, translating scientific data into actionable recommendations for the CDC and HHS. In recent years, public skepticism toward vaccines has pressured policymakers to prioritize transparency and credibility. By reconstituting ACIP in June 2025, Secretary Robert F. Kennedy, Jr. signaled a strategic shift toward inclusive, evidence‑driven deliberations designed to restore trust and improve uptake of immunizations across diverse populations.

The two new members, Dr. Sean G. Downing and Dr. Angelina Farella, bring a rare blend of internal medicine, pediatrics, and entrepreneurial experience. Dr. Downing’s two‑decade career spans primary‑care practice, emergency medicine, and care for uninsured patients, offering a comprehensive view of vaccine impact across age groups. Dr. Farella’s long‑standing pediatric practice and academic roles provide insight into child health outcomes and the practical challenges families face when navigating immunization schedules. Their frontline perspectives are expected to enrich ACIP discussions with real‑world evidence, ensuring recommendations reflect both scientific rigor and patient realities.

The appointments carry significant implications for vaccine strategy and public health communication. With seasoned clinicians on board, ACIP can more effectively address vaccine hesitancy by articulating clear, relatable guidance rooted in everyday clinical practice. This alignment of expertise and transparency is likely to enhance the credibility of CDC vaccine recommendations, fostering higher compliance and better protection against preventable diseases. As the United States confronts evolving pathogen threats, a trusted ACIP will be pivotal in shaping swift, evidence‑based immunization responses.